Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L D Martin

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
The Journal of Biological Chemistry|May 30, 1998
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migrationJ R White, J M Lee, P R Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonistH M Sarau, D E Griswold, W Potts, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapyJo Ann Janovick, M David Stewart, Darla Jacob, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
The Journal of Biological Chemistry|May 30, 1998
Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migrationJ R White, J M Lee, P R Young, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1997
Nonpeptide tachykinin receptor antagonists: I. Pharmacological and pharmacokinetic characterization of SB 223412, a novel, potent and selective neurokinin-3 receptor antagonistH M Sarau, D E Griswold, W Potts, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 11, 2013
Restoration of testis function in hypogonadotropic hypogonadal mice harboring a misfolded GnRHR mutant by pharmacoperone drug therapyJo Ann Janovick, M David Stewart, Darla Jacob, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 19, 2000
Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonistH M Sarau, D E Griswold, B Bush, et al.
Prostaglandins, Leukotrienes, and Essential Fatty Acids|September 7, 1999
In vitro and in vivo pharmacological characterization of SB 201993, an eicosanoid-like LTB4 receptor antagonist with anti-inflammatory activityH M Sarau, J J Foley, D B Schmidt, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 1, 2007
Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party databaseR Saccardi, T Kozak, C Bocelli-Tyndall, et al.
Pageof 9